Hepatic hyperplasia and cancer in rats: Alterations in copper metabolism

Carcinogenesis

Volumn 20, Issue 6, 1999, Pages 1091-1096

  Eagon, Patricia K ^a,b   Teepe, Annette G ^b   Elm, Mary S ^a,b   Tadic, Stasa D ^a,b   Epley, Marilyn J ^a,b   Beiler, Bonnie E ^b   Shinozuka, Hisashi ^b   Rao, Kalipatnapu N ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; CLOFIBRATE; COPPER; IRON; MESSENGER RNA; METAL; METALLOTHIONEIN; PEROXISOME PROLIFERATOR; PHTHALIC ACID BIS(2 ETHYLHEXYL) ESTER; PIRINIXIL; SCAVENGER; ZINC;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DAMAGE; CERULOPLASMIN BLOOD LEVEL; CONTROLLED STUDY; COPPER METABOLISM; DISEASE COURSE; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; LIVER CANCER; LIVER CELL CARCINOMA; LIVER HYPERPLASIA; LIVER TUMOR; MALE; METAL METABOLISM; NONHUMAN; OXIDATION; PRIORITY JOURNAL; RAT; TISSUE; WILSON DISEASE;

ANIMALS; CERULOPLASMIN; CLOFIBRIC ACID; COPPER; DIETHYLHEXYL PHTHALATE; HYPERPLASIA; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; MALE; METALLOTHIONEIN; PYRIMIDINES; RATS; RATS, INBRED F344; RNA, MESSENGER;

EID: 0032985479     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/20.6.1091     Document Type: Article

References (54)

1. Perera, F.P. (1991) Perspectives on the risk assessment for nongenotoxic carcinogens and tumor promoters. Environ. Health Perspect., 94, 231-235.
2. Marsman, D.S., Goldsworthy, T.L. and Popp, J.A. (1992) Contrasting hepatocyte and peroxisome proliferation, lipofuscin accumulation and cell turnover for the hepatocarcinogen Wy-14 643 and clofibric acid. Carcinogenesis, 13, 1011-1017.
3. Reddy, J.K. and Lalwani, N.D. (1983) Carcinogenesis by hepatic peroxisome proliferators: evaluation of the risk of hypolipidemic drugs and industrial plasticizers to humans. CRC Crit. Rev. Toxicol., 12, 1-58.
4. Reddy, J.K. and Rao, M.S. (1977) Transplantable pancreatic carcinoma of the rat. Science, 198, 78-80.
5. Cook, J.C., Hurtt, M.E., Frame, S.R. and Biegel, L.B. (1994) Mechanism of extrahepatic tumor induction by peroxisome proliferators in Crl:CD ®BR (CD) rats. Toxicologist, 14, Abstract no. 1163.
6. Orner, G.A., Matthews, C., Hendricks, J.D., Carpenter, H.M., Bailey, G.S. and Williams, D.E. (1995) Dehydroepiandrosterone is a complete hepatocarcinogen and potent tumor promoter in the absence of peroxisome proliferation in rainbow trout. Carcinogenesis, 16, 2893-2898.
7. Ledda-Columbano, G.M. and Columbano, A. (1994) Compensatory cell proliferation, mitogen-induced liver growth and hepatocarcinogenesis in the rat. In Cockburn, A. and Smith, L. (eds) Nongenotoxic Carcinogenesis. Springer-Verlag, New York, pp. 121-139.
8. Roberts, R.A. (1996) Non-genotoxic hepatocarcinogenesis: suppression of apoptosis by peroxisome proliferators. Ann. NY Acad. Sci., 804, 588-611.
9. Roberts, R.A., James, N.H., Woodyatt, N.J., Macdonald, N. and Tugwood, J.D. (1998) Evidence for the suppression of apoptosis by the peroxisome proliferator activated receptor alpha (PPAR alpha). Carcinogenesis, 19, 43-48.
10. Rusyn, I. Tsukamoto, H. and Thurman, R.G. (1998) WY-14 643 rapidly activates nuclear factor kappaB in Kupffer cells before hepatocytes. Carcinogenesis, 19, 1217-1222.
11. Eagon, P.K., Chandar, N., Epley, M.J., Elm, M.S., Brady, E.P. and Rao, K.N. (1994) Di(2-ethylhexyl)-phthalate-induced changes in liver estrogen metabolism and hyperplasia. Int. J. Cancer, 58, 736-743.
12. Eagon, P.K., Elm, M.S., Epley, M.J., Shinozuka, H. and Rao, K.N. (1996) Sex steroid metabolism and receptor status in hepatic hyperplasia and cancer in rats. Gastroenterology, 110, 1199-1207.
13. Porter, L.E., Van Thiel, D.H. and Eagon, P.K. (1987) Estrogens and progestins as tumor inducers. Semin. Liver Dis., 7, 24-31.
14. Eagon, P.K., Elm, M.S., Dugani, A., Shinozuka, H., Rao, K.N. and Villa, E. (1996) Loss of estrogen receptor expression and detection of a variant estrogen receptor transcript in a rat model of nongenotoxic hepatocarcinogenesis. Hepatology, 24, 340A (abstract no. 856).
15. Reddy, J.K. (1994) Peroxisomal lipid metabolism. Annu. Rev. Nutr., 14, 343-70.
16. Zakim, D., Paradini, R.S. and Herman, R.H. (1970) Effect of clofibrate (ethyl-chlorophenoxy-isobutyrate) feeding on glycolytic and lipogenic enzymes and hepatic glycogen synthesis in the rat. Biochem. Pharmacol., 19, 305-310.
17. West, D.W. and Shand, J.H. (1994) The effects of clofibrate and bezafibrate on cholesterol metabolism in the liver of the male rat. Lipids, 29, 747-752.
18. Rao, K.N., Elm, MS., Kelly, R.H., Chandar, N., Brady, E.P., Rao, B., Shinozuka, H. and Eagon, P.K. (1997) Hepatic hyperplasia and cancer in rats: metabolic alterations associated with cell growth. Gastroenterology, 113, 238-248.
19. Hertz, R., Aurbach, R., Hashimoto, T. and Bar-Tana, J. (1991) Thyromimetic effects of peroxisomal proliferators in rat liver. Biochem. J., 274, 745-751.
20. Cai, Y., Nelson, B.D., Li, R., Luciakova, K. and DePierre, J.W. (1996) Thyromimetic action of the peroxisome proliferators clofibrate, perfluorooctanoic acid and acetylsalicylic acid includes changes in mRNA levels for certain genes involved in mitochondrial biogenesis. Arch. Biochem. Biophys., 325, 107-112.
21. Linder, M. and Hazegh-Azam, M. (1996) Copper biochemistry and molecular biology. Am. J. Clin. Nutr., 63, 797S-811S.
22. Kodama, H. (1996) Genetic disorders of copper metabolism. In Chang, L.W. (ed.) Toxicology of Metals. Lewis Publishers, New York, pp. 371-386.
23. Yamaguchi, Y., Heiny, M.E. and Gitlin, J.D. (1993) Isolation and characterization of a human liver cDNA as a candidate gene for Wilson's disease. Biochem. Biophys Res. Commun., 197, 271-277.
24. Sato, M. and Gitlin, J.D. (1991) Mechanisms of copper incorporation during the biosynthesis of human ceruloplasmin. J. Biol. Chem., 266, 5128-5134.
25. Harris, Z.L. and Gitlin, J.D. (1996) Genetic and molecular basis for copper toxicity. Am. J. Clin. Nutr., 63, 836S-841S.
26. Yamaguchi, Y., Heiny, M.E., Shimizu, N., Aoki, T. and Gitlin, J.D. (1994) Expression of the Wilson disease gene is deficient in the Long-Evans Cinnamon rat. Biochem. J., 301, 1-4.
27. Li,Y., Togashi, Y., Sato, S. et al. (1991) Abnormal copper accumulation in non-cancerous and cancerous liver tissues of LEC rats developing hereditary hepatitis and spontaneous hepatoma. Jpn J. Cancer Res., 82, 490-492.
28. Jong-Hon, K., Togashi, Y., Kasai, H., Hosokawa, M. and Takeichi, N. (1993) Prevention of spontaneous hepatocellular carcinoma in Long-Evans Cinnamon rats with hereditary hepatitis by administration of D-penicillamine. Hepatology, 18, 614-620.
29. Sone, H., Maeda, M., Wakabayashi, K., Takeichi, N., Mori, M., Sugimura, T. and Nagao, M. (1996) Inhibition of hereditary hepatitis and liver tumor development in Long-Evans Cinnamon rats by the copper-chelating agent trientine dihydrochloride. Hepalology, 23, 764-770.
30. Sokol, R.J., Devereaux, M., Mierau.G.W., Hambidge, K.M. and Shikes, R.H. (1990) Oxidant injury to hepatic mitochondrial lipids in rats with dietary copper overload: modification by vitamin E deficiency. Gastroenterology, 99, 1061-1071.
31. Arora, A.S. and Gores, G. J. (1996) The role of metals in ischemia/reperfusion injury in the liver. Semin. Liver Dis., 16, 31-39.
32. Sokol, R.J. (1996) Antioxidant defenses in metal-induced liver damage. Semin. Liver Dis., 16, 39-46.
33. Schilsky, M.L. (1996) Wilson's Disease: genetic basis of copper toxicity and natural history. Semin. Liver Dis., 16, 83-95.
34. Chomczynski, P. and Sacchi, N. (1987) Single-step method of RNA isolation by guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162, 156-159.
35. Bingle, C.D., Fleming, R.E. and Gitlin, J.D. (1993) Interaction of CCAAT/ enhancer-binding protein alpha and beta with the rat caeruloplasmin gene promoter. Biochem. J., 294, 473-479.
36. Andersen, R.D., Birren, B.W., Taplitz, S.J. and Herschman, H.R. (1986) Rat metallothionein-1 structural gene and three pseudogenes, one of which contains 5′-regulatory sequences. Mol. Cell. Biol., 6, 302-314.
37. Sunderman, F.W. and Nomoto.S. (1970) Measurement of human serum ceruloplasmin by its p-phenylaminediamine oxidase activity. Clin. Chem., 16, 903-910.
38. Hertz, R., Seckbach. M., Zakin, M.M. and Bar-Tana, J. (1996) Transcriptional suppression of the transferrin gene by hypolipidemic peroxisome proliferators. J. Biol. Chem., 271, 218-224.
39. Williams, G.M. and Yamamoto, R.S. (1972) Absence of stainable iron from preneoplastic and neoplastic lesions in rat liver in 8-hydroxyquinoline-induced siderosis. J. Natl Cancer Inst., 49, 685-692.
40. Cater, K.C., Gandolfi, A.J. and Sipes, I.G. (1985) Characterization of dimethylnitrosamine-induced focal and nodular lesions in the liver of newborn mice. Toxicol. Pathol., 13, 3-9.
41. Poirier, L.A. (1996) An introduction to selected concepts in metal carcinogenesis. In Chang.L.W. (ed.) Toxicology of Metals. Lewis Publisher, New York, pp. 287-298.
42. Sugawara, N., Sugawara, C., Katakura, M., Takahashi, H. and Mori, M. (1991) Copper metabolism in the LEC rat: involvement of induction of metallothionein and disposition of zinc and iron. Experientia, 47, 1060-1063.
43. waf l/cip 1. Carcinogenesis, 17, 2157-2161.
44. Rao, K.N., Chandar, N., Elm, M.S., Shinozuka, H. and Eagon, P.K. (1998) Role of copper and zinc in hepatic hyperplasia and hepatocellular carcinoma in rats by peroxisome proliferators. Proc. Am. Assoc. Cancer Res., abstract no. 2284.
45. Li, Y., Trush, M.A. and Yager, J.D. (1994) DNA damage caused by reactive oxygen species originating from a copper-dependent oxidation of the 2-hydroxy catechol of estradiol. Carcinogenesis, 15, 1421-1427.
46. Suzuki, K.T, Rui, M., Ueda, J.-I. and Ozawa, T. (1996) Production of hydroxyl radicals by copper-containing metallothionein; roles as prooxidant. Toxicol. Appl. Pharmacol., 141, 231-237.
47. Bremner, I., Hoekstra, W.G., Davies, N.T. and Young, B.W. (1978) Effect of zinc status of rats on the synthesis and degradation of copper-induced metallothioneins. Biochem. J., 174, 883-892.
48. Myers, B.M., Prendergast, F.G., Holman, R., Kuntz, S.M. and LaRusso, N.F. (1993) Alterations in hepatocyte lysosomes in experimental hepatic copper overload in rats. Gastroenterology, 105, 1814-1823.
49. Gross, J.B. Jr, Myers, B.M. Kost, L.J., Kuntz, S.M. and LaRusso, N.F. (1989) Biliary copper excretion by hepatocyte lysosomes in the rat. Major excretory pathway in experimental copper overload. J. Clin. Invest., 83, 30-39.
50. Lake, B.G., Gray, J.T.B., Korosi, S.A. and Walters, D.G. (1989). Nafenopin, a peroxisome proliferator, depletes hepatic vitamin E content and elevates plasma oxidised glutathione levels in rats. Toxicol. Lett. 45, 221-229.
51. Ciriolo, M.R., Mavelli, I., Rotilio, G., Borzatta, V., Cristofari, N. and Stanzani, L. (1982) Decrease of superoxide dismutase and glutathione peroxidase in liver of rats treated with hypolipidemic drugs. FEBS Lett., 144, 264-248.
52. Sawaki, M., Enomoto, K., Hattori, A., Tsuzuki, N., Sugawara, N. and Mori, M. (1994) Role of copper accumulation and metallothionein induction in spontaneous liver cancer development in LEC rats. Carcinogenesis, 15, 1833-1837.
53. Sternlieb, I., Quintana, N., Volenberg, I. and Schilsky, M.L. (1995) An array of mitochondrial alterations in the hepatocytes of Long-Evans Cinnamon rats. Hepatology, 22, 1782-1787
54. Mansouri, A., Gaou, I., Fromenty, B., Berson, A., Letteron, P., DeGott, C., Erlinger, S. and Pessayre, D. (1997) Premature oxidative aging of hepatic mitochondrial DNA in Wilson's disease. Gastroenterology, 113, 509-605.